Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Clinical trial

How Patient Engagement Improves Clinical Trial Success
Posted in
  • Case Studies & Trends
  • Your POV

How Patient Engagement Improves Clinical Trial Success

Patient engagement is emerging as a critical factor in the success of clinical trials, particularly in … How Patient Engagement Improves Clinical Trial SuccessRead more

by Jayshree Gondane•February 28, 2026February 28, 2026•0
The Hidden Costs of Failed Clinical Trials
Posted in
  • Strategy & Execution

The Hidden Costs of Failed Clinical Trials

Clinical trial failure is often framed as a scientific setback – a missed endpoint, an unexpected … The Hidden Costs of Failed Clinical TrialsRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
Why Drugs Fail After Phase I in the U.S. Market
Posted in
  • Industry Landscape
  • Regulatory Compliance

Why Drugs Fail After Phase I in the U.S. Market

In the United States, roughly 12 percent of drugs that enter clinical testing ultimately receive approval … Why Drugs Fail After Phase I in the U.S. MarketRead more

by Jayshree Gondane•February 16, 2026February 16, 2026•0
Why Clinical Trial Data Fails to Translate Into Market Success
Posted in
  • Industry Landscape
  • Strategy & Execution

Why Clinical Trial Data Fails to Translate Into Market Success

A therapy can clear Phase III, secure FDA approval, and generate headline optimism-only to miss revenue … Why Clinical Trial Data Fails to Translate Into Market SuccessRead more

by Jayshree Gondane•February 15, 2026February 15, 2026•0
How Lack of Patient-Centricity Hurts Clinical Trial Outcomes
Posted in
  • Strategy & Execution

How Lack of Patient-Centricity Hurts Clinical Trial Outcomes

In 2023, the FDA’s Center for Drug Evaluation and Research approved 55 novel drugs, continuing a … How Lack of Patient-Centricity Hurts Clinical Trial OutcomesRead more

by Jayshree Gondane•February 12, 2026February 12, 2026•0

Recent Posts

  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
  • FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know Now
  • The Uncomfortable Truth About Pharmaceutical Marketing Failure
  • The Truth About Pharmaceutical Marketing in the United States

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A